Deals
CVS Deal for Omnicare Seen Avoiding PharMerica Antitrust Stumble
This article is for subscribers only.
CVS Health Corp. will probably win approval from antitrust officials to buy nursing-home pharmacy company Omnicare Inc., according to lawyers and equity analysts, even after regulators stood against Omnicare’s bid for PharMerica Corp. in 2012.
CVS and Omnicare don’t compete directly, which will ease the competition review, though regulators will likely scrutinize the increased buying power CVS will gain with more customers, said Amanda Wait, an antitrust lawyer at Hunton & Williams LLP in Washington.